Precigen (PGEN) Cash from Operations (2012 - 2026)
Precigen (PGEN) reported Cash from Operations of 43827000.0 for Q1 2026, down 168.47% year-over-year from 64013221.35 in Q1 2025, and down 86.82% quarter-over-quarter from 23460000.0 in Q4 2025.
Precigen (PGEN) Cash from Operations (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Cash from Operations data on file, last reported at 43827000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 43827000.0, down 168.47% year-over-year; the trailing twelve-month figure through Mar 2026 was 115333000.0 (down 63.81% YoY), and the FY2025 annual result was 87831000.0, down 28.84% from the prior year.
- Cash from Operations fell to 43827000.0 in Q1 2026 per PGEN's latest filing, from 23460000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 7053000.0 in Q2 2022 and troughed at 43827000.0 in Q1 2026.
- A 5-year average of 19518000.0 and a median of 18388000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations soared 47.72% in 2024, then tumbled 184.61% in 2025.
- A 5-year view of Cash from Operations shows it stood at 15396000.0 in 2022, then decreased by 2.4% to 15766000.0 in 2023, then soared by 47.72% to 8243000.0 in 2024, then plunged by 184.61% to 23460000.0 in 2025, then tumbled by 86.82% to 43827000.0 in 2026.
- Business Quant data shows PGEN's Cash from Operations at 43827000.0 in Q1 2026, 23460000.0 in Q4 2025, and 29069000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | -43.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.83 Mn |
| Mar 31, 2026 | -43.83 Mn |
| Dec 31, 2025 | -23.46 Mn |
| Dec 31, 2025 | -23.46 Mn |
| Sep 30, 2025 | -29.07 Mn |
| Sep 30, 2025 | -29.07 Mn |
| Jun 30, 2025 | -18.98 Mn |
| Jun 30, 2025 | -18.98 Mn |
| Mar 31, 2025 | -16.33 Mn |
| Mar 31, 2025 | -16.33 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Sep 30, 2024 | -22.73 Mn |
| Sep 30, 2024 | -22.73 Mn |
| Jun 30, 2024 | -23.11 Mn |
| Jun 30, 2024 | -23.11 Mn |
| Mar 31, 2024 | -14.09 Mn |
| Mar 31, 2024 | -14.09 Mn |
| Dec 31, 2023 | -15.77 Mn |
| Dec 31, 2023 | -15.77 Mn |